IGCClosing triangle and gap indicator. Possibly another drop to .40s or maybe even .30s This has been a hopeful bottom for many markets.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.225EUR
−10.62 MEUR
840.55 KEUR
45.90 M
About IGC Pharma, Inc.
Sector
Industry
CEO
Ram Mukunda
Website
Headquarters
Potomac
Employees (FY)
61
Founded
2005
FIGI
BBG000W6KDM5
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.
IgcI'm really for new adventure with this pump and dumb stock.
Buying zone 0.45 - 0.75
Never invest money that you can't afford to lose
Good luck
IGC India Globalization Capital bullish newsAfter the last pump and dump of IGC caused by Cohort 2 of IGC`s Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients
now India Globalization Capital comes with another bullish news on the subject: the cannabis-based investigational drug IGC-AD1 was safe and well-tolerated by the Alzheimer’s tr
IGC updateCongratz if you followed my last prediction:
I updated the chart, see above.
I am still confident will we step even higher, but first we have to accept the next pullback.
IGC PullbackIGC started yesterday pretty good, I expect a pullback followed by an bullrun until earnings.
Risk/Reward looks good - Stop Loss at 1.44$.
Lotto Ticket Play, Highly ManipulatedJust something I remembered from a few years back. Love that tradingview play button, so figured I'd post the look just to see what will happen. Noticed it was moving.
Back in 2018, for awhile it was the darling of speculatives in the weed stock sector, rising from sub $1.00 to $15.00. That was
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange IGC PHARMA INC. DL -,01 stocks are traded under the ticker IGS1.
We've gathered analysts' opinions on IGC PHARMA INC. DL -,01 future price: according to them, IGS1 price has a max estimate of 3.01 EUR and a min estimate of 3.01 EUR. Watch IGS1 chart and read a more detailed IGC PHARMA INC. DL -,01 stock forecast: see what analysts think of IGC PHARMA INC. DL -,01 and suggest that you do with its stocks.
IGS1 reached its all-time high on Oct 2, 2018 with the price of 12.450 EUR, and its all-time low was 0.095 EUR and was reached on Jan 2, 2019. View more price dynamics on IGS1 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track IGC PHARMA INC. DL -,01 financials in yearly and quarterly reports right on TradingView.
IGC PHARMA INC. DL -,01 is going to release the next earnings report on Jun 20, 2024. Keep track of upcoming events with our Earnings Calendar.
IGS1 earnings for the last quarter are −0.08 EUR per share, whereas the estimation was −0.04 EUR resulting in a −125.00% surprise. The estimated earnings for the next quarter are −0.04 EUR per share. See more details about IGC PHARMA INC. DL -,01 earnings.
IGC PHARMA INC. DL -,01 revenue for the last quarter amounts to 184.83 K EUR despite the estimated figure of 362.40 K EUR. In the next quarter revenue is expected to reach 178.87 K EUR.
IGS1 net income for the last quarter is −5.06 M EUR, while the quarter before that showed −2.32 M EUR of net income which accounts for −118.39% change. Track more IGC PHARMA INC. DL -,01 financial stats to get the full picture.
No, IGS1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 18, 2024, the company has 61.00 employees. See our rating of the largest employees — is IGC PHARMA INC. DL -,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IGC PHARMA INC. DL -,01 EBITDA is −10.00 M EUR, and current EBITDA margin is −1.20 K%. See more stats in IGC PHARMA INC. DL -,01 financial statements.
Like other stocks, IGS1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IGC PHARMA INC. DL -,01 stock right from TradingView charts — choose your broker and connect to your account.